Get our introductory offer at only
*$0.99/month for first 3 months
$29.90/month for the next 9 months
ROCHE'S bid to muscle in on Shire's share of the US$11 billion haemophilia drug market took a new, contentious turn this weekend when the British drugmaker won a court injunction against how the Swiss drugmaker talks about its new medicine.
Shire's injunction on Sunday in a...